Should All Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease Receive an SGLT2 Inhibitor?

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC6118832 | biostudies-literature | 2018 Jul-Aug

REPOSITORIES: biostudies-literature